MOLINA HEALTHCARE, INC. is an SEC registrant, filing under CIK 0001179929, classified as hospital and medical service plans. We track it alongside the rest of the Health Care sector.
MOH Form 4 activity by transaction type, last 90 days
Form 4 transaction type
Transactions
Shares
Total value
Grant or award
9
2,736
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MOH insider transactions (Form 4)
31
84 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 3.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on October 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on July 1, 2026.
Footnote F2 (price): In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and… Full note on SEC EDGAR
Footnote F2 (price): In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and… Full note on SEC EDGAR
Footnote F2 (price): In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and… Full note on SEC EDGAR
Footnote F1 (price): Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $186.01 to $186.86. The Reporting Person hereby undertakes to provide upon request of the Commission staff full… Full note on SEC EDGAR
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on April 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on April 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on April 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on April 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on April 1, 2026.
Footnote F2 (shares): The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common… Full note on SEC EDGAR
Footnote F3 (price): Represents the closing price of the Issuer's common stock on April 1, 2026.
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
MOLINA HEALTHCARE, INC. (MOH) had 9 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for MOH runs to 84 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MOH stock?
No insider purchases of MOH were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling MOH stock?
No insider sales of MOH were filed in the last 90 days. 13 sales are on record for this company.
Where can I see MOH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MOH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of MOH beside its insider purchases is in the Congress Tracker.
Jeff D. Barlow - OfficerOpen-market sale$3.31M
Ronna Romney - Director
Francis S. Soistman Jr. - Director
James Woys - Officer
Gilbert Ray Cisneros, Jr.Democrat, CA-31
